Between 2025 and 2030, the pharmaceutical cold chain logistics market across ASEAN—led by Thailand, Singapore, and Malaysia—is projected to expand from $4.7B to $11.8B (CAGR 20.3%). The surge is fueled by temperature-sensitive vaccine and biologics demand, infrastructure modernization, and risk management frameworks adopted post-pandemic. Thailand, accounting for 26% of ASEAN’s cold chain capacity, anchors regional resilience with strategic investments in GMP-certified storage, IoT-based monitoring, and multi-modal cold freight corridors. By 2030, cold chain losses are forecast to decline by 48%, strengthening pharma reliability and export competitiveness.